首页> 外文期刊>Journal of applied clinical medical physics / >Technical Note: Development of 3D‐printed breast phantoms for end‐to‐end testing of whole breast volumetric arc radiotherapy
【24h】

Technical Note: Development of 3D‐printed breast phantoms for end‐to‐end testing of whole breast volumetric arc radiotherapy

机译:技术说明:开发3D印刷的乳房幻影,用于全乳房容量弧放射治疗的端到端测试

获取原文
       

摘要

End‐to‐end testing of a new breast radiotherapy technique preferably requires realistic phantom geometries, which is challenging to achieve using currently commercially available solutions. We have developed a series of three‐dimensional (3D)‐printed breast phantoms, with ionization chamber and radiochromic film inserts, which can be attached to a commercial anthropomorphic thorax phantom. A contoured left breast from a patient’s planning CT was mapped onto a CT of the CIRS E2E thorax phantom (CIRS Inc.) and cropped to fit the surface. Four versions of the breast were 3D printed, containing a cavity for an ionization chamber and slits for radiochromic film insertion in the three cardinal planes, respectively. The phantoms were fully compatible with surface scanning technology used for setup. The phantoms were validated using a whole‐breast volumetric modulated arc therapy protocol with a simultaneous integrated boost to the tumor bed (VMAT‐SIB). Six patient plans and one original plan on the breast phantom were verified with planar portal imaging, point dose, and film measurements in the MultiCube phantom and planar γ‐analysis using ArcCHECK diode array. Six patient plans were recalculated on the breast phantom (hybrid plans) and delivered with point dose and film measurements with 3% (local)/2?mm γ‐analysis. One complete end‐to‐end test on the breast phantom was performed. All plan quality verifications had point dose differences below 2.4% from the calculated dose and γ‐agreement scores (γAS)??87.3% for film measurements in the MultiCube, portal dosimetry, and ArcCHECK. Point dose differences in the 3D‐printed phantoms were below 2.6% (median ?1.4%, range ?2.6%; 0.3%). Median γAS was 96.4% (range 80.1%–99.7%) for all film inserts. The proposed 3D‐printed attachable breast dosimetry phantoms have been shown to be a valuable tool for end‐to‐end testing of a new radiotherapy protocol. The workflow described in this report can aid users to create their own phantom‐specific breast 3D‐printed phantoms.
机译:新的乳房放射疗法技术的端到端测试优选地需要现实的幻象几何形状,这是使用当前市售的解决方案来实现的具有挑战性。我们开发了一系列三维(3D)孔型乳房幻影,具有电离室和放射刻度膜插入物,其可以附着在商业拟人胸腔体内。将患者计划CT的左乳房映射到CIRS E2E胸部幻像(CIRS Inc.)的CT上并裁剪以适合表面。乳房的四个版本是3D印刷,含有用于电离室的空腔,以及用于在三个基本平面中的用于放射圆形膜插入的狭缝。幽灵与用于设置的表面扫描技术完全兼容。使用全乳腺体积调制的ARC治疗方案进行验证的杂色,同时集成到肿瘤床(VMAT-SIB)。使用ArcCheck二极管阵列进行平面门静脉成像,点剂量和Planarγ分析的平面门静脉成像,点剂量和薄膜测量,验证了六个患者计划和一个原始计划。在乳房幻影(混合计划)上重新计算六个患者计划,并用3%(局部)/2Ωmmγ分析的点剂量和薄膜测量输送。进行乳房幻影的一个完整的端到端测试。所有计划质量验证都有低于2.4%的点剂量差异,从计算的剂量和γ-Anglegres(γAs)?>?87.3%用于多尺寸的薄膜测量值,门户网球剂量和ArcCheck。 3D印刷幻影的点剂量差异低于2.6%(中位数?1.4%,范围?2.6%; 0.3%)。所有薄膜插入件的中位γAs为96.4%(范围80.1%-99.7%)。所提出的3D印刷的可连接乳房剂量测定晶粒已被证明是用于新的放射治疗方案的端到端测试的有价值的工具。本报告中描述的工作流程可以帮助用户创建自己的幻像特定的乳房3D印刷的幻影。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号